Sotera Health Company (SHC)
USD 12.38
(2.31%)
USD 12.38
(2.31%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.13 Billion USD | 0.41% |
| 2022 | 3.11 Billion USD | 11.77% |
| 2021 | 2.78 Billion USD | 1.02% |
| 2020 | 2.76 Billion USD | 7.0% |
| 2019 | 2.58 Billion USD | -4.72% |
| 2018 | 2.7 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 3.05 Billion USD | -0.06% |
| 2024 Q1 | 3.05 Billion USD | -2.26% |
| 2024 Q3 | 3.14 Billion USD | 2.97% |
| 2023 Q4 | 3.13 Billion USD | 3.09% |
| 2023 Q2 | 3.07 Billion USD | -9.94% |
| 2023 Q1 | 3.41 Billion USD | 9.51% |
| 2023 Q3 | 3.03 Billion USD | -1.25% |
| 2023 FY | 3.13 Billion USD | 0.41% |
| 2022 Q3 | 2.81 Billion USD | -1.02% |
| 2022 FY | 3.11 Billion USD | 11.77% |
| 2022 Q4 | 3.11 Billion USD | 10.93% |
| 2022 Q2 | 2.83 Billion USD | 0.14% |
| 2022 Q1 | 2.83 Billion USD | 1.66% |
| 2021 Q3 | 2.74 Billion USD | -3.8% |
| 2021 Q4 | 2.78 Billion USD | 1.7% |
| 2021 FY | 2.78 Billion USD | 1.02% |
| 2021 Q1 | 2.77 Billion USD | 0.57% |
| 2021 Q2 | 2.85 Billion USD | 2.67% |
| 2020 Q2 | 2.55 Billion USD | 0.0% |
| 2020 FY | 2.76 Billion USD | 7.0% |
| 2020 Q3 | 2.7 Billion USD | 5.51% |
| 2020 Q4 | 2.76 Billion USD | 2.27% |
| 2020 Q1 | - USD | -100.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 2.58 Billion USD | -4.72% |
| 2019 Q4 | 2.58 Billion USD | 0.0% |
| 2018 FY | 2.7 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 197.4 Million USD | -1485.786% |
| Biodesix, Inc. | 99.09 Million USD | -3058.977% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -37975.779% |
| Castle Biosciences, Inc. | 477.81 Million USD | -555.159% |
| DarioHealth Corp. | 96.38 Million USD | -3147.694% |
| Exact Sciences Corporation | 6.47 Billion USD | 51.626% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | 3.973% |
| Illumina, Inc. | 10.11 Billion USD | 69.039% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | -22619.001% |
| iSpecimen Inc. | 15.81 Million USD | -19688.817% |
| Standard BioTools Inc. | 323.06 Million USD | -868.969% |
| 23andMe Holding Co. | 395.16 Million USD | -692.176% |
| Medpace Holdings, Inc. | 1.65 Billion USD | -88.941% |
| NeoGenomics, Inc. | 1.68 Billion USD | -86.198% |
| Inotiv, Inc. | 856.53 Million USD | -265.477% |
| Psychemedics Corporation | 13.27 Million USD | -23490.203% |
| Prenetics Global Limited | 254.17 Million USD | -1131.622% |
| Precipio, Inc. | 18.1 Million USD | -17194.183% |
| RadNet, Inc. | 2.88 Billion USD | -8.443% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -3499.26% |
| Exagen Inc. | 56.94 Million USD | -5397.366% |
| Natera, Inc. | 1.45 Billion USD | -114.835% |
| Aspira Women's Health Inc. | 6.26 Million USD | -49890.738% |
| Neogen Corporation | 4.58 Billion USD | 31.712% |
| Myriad Genetics, Inc. | 1.19 Billion USD | -161.151% |
| ICON Public Limited Company | 16.98 Billion USD | 81.575% |
| Bionano Genomics, Inc. | 214.4 Million USD | -1360.057% |
| CareDx, Inc | 484.61 Million USD | -545.96% |
| Check-Cap Ltd. | 25.01 Million USD | -12413.171% |
| Twist Bioscience Corporation | 776.4 Million USD | -303.195% |
| Guardant Health, Inc. | 1.78 Billion USD | -75.234% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -27360.323% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | -145.888% |
| Sera Prognostics, Inc. | 95.44 Million USD | -3179.953% |
| OPKO Health, Inc. | 2.01 Billion USD | -55.611% |
| Personalis, Inc. | 225.09 Million USD | -1290.686% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | -22830.831% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -3499.26% |
| MDxHealth SA | 129.13 Million USD | -2324.202% |
| Prenetics Global Limited | 254.17 Million USD | -1131.622% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -46248.125% |
| Mainz Biomed B.V. | 15.4 Million USD | -20215.493% |
| Trinity Biotech plc | 59.43 Million USD | -5166.964% |
| Neuronetics, Inc. | 115.83 Million USD | -2602.575% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -37975.779% |